Destination therapy: The new gold standard treatment for heart failure patients with left ventricular assist devices

General Thoracic and Cardiovascular Surgery

Volumn 61, Issue 3, 2013, Pages 111-117

  Yamakawa, Michael ^a   Kyo, Shunei ^a   Yamakawa, Sean ^a   Ono, Minoru ^a   Kinugawa, Koichiro ^a   Nishimura, Takashi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Bridge to transplantation; Destination therapy; Heart failure; Heart transplantation; Left ventricular assist device

Indexed keywords

ACUTE HEART FAILURE; CLINICAL EFFECTIVENESS; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; JAPAN; LEFT VENTRICULAR ASSIST DEVICE; LIFESPAN; OPERATION DURATION; ORGAN DONOR; OUTCOME ASSESSMENT; PATIENT SELECTION; PULMONARY HYPERTENSION; PULSATILE FLOW; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL TECHNOLOGY; SURVIVAL RATE; SURVIVAL TIME;

HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; JAPAN; PROSTHESIS DESIGN; SURVIVAL RATE;

EID: 84879550142     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-012-0181-5     Document Type: Review

References (22)

1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-43.
2. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-51.
3. Yamane T, Kyo S, Matsuda H, et al. Japanese guidance for ventricular assist devices/total artificial hearts. Artif Organs. 2010;34(9):699-702.
4. Omoto R, Kyo S, Nishimura M, Matsuda H, Matsumiya G, Kitamura S, et al. Japanese multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system. J Artif Organs. 2005;8(1):34-40.
5. Kyo S, Minami T, Nushimira T, Ono M. New era for therapeutic strategy for heart failure: destination therapy by left ventricular assist device. J Cardiol. 2012;59(2):101-9.
6. Kurihara C, Ono M, Nishimura T, Saito A, Taketani T, Hisagi M, et al. Use of DuraHeart support for more than 1 year as the first successful bridge to heart transplantation in Japan. J Artif Organs. 2011;14(1):67-9.
7. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, et al. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device. Circ J. 2012;76(2):372-6.
8. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty- eighth Adult Heart Transplant Report - 2011. J Heart Lung Transplant. 2011.
9. Stewart GC, Givertz MM. Mechanical circulatory support for advanced heart failure - patients and technology in evolution. Circulation. 2012;125(10):1304-15.
10. Ventura PA, Alharethi R, Budge D, Reid BB, Horne BD, Mason NO, et al. Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices. Clin Transplant. 2011;25(4):E390-5.
11. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, et al. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2011;30(8):854-61.
12. Garbade J, Bittner HB, Barten MJ, Mohr FW, et al. Current trends in implantable left ventricular assist devices. Cardiol Res Pract. 2011;2011:290561.
13. Stevenson LW, Hunt SA. A bridge far enough? Circulation 2012. [Epub ahead of print].
14. Milano CA, Simeone AA. Mechanical circulatory support: devices, outcomes, and complications. Heart Fail Rev. 2012.
15. Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9-17.
16. Long JW, Kfoury AG, Slaughter MS, Silver M, Milano C, Rogers J, et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005;11(3):133-8.
17. Stewart GC, Stevenson LW. Keeping left ventricular assist device acceleration on track. Circulation. 2011;123:1559-68.
18. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS Annual Report - the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(2):115-23.
19. Egawa H, Tanabe K, Fukushima N, Date H, Sugitani A, Haga H. Current status of organ transplantation in Japan. Am J Transplant. 2012;12:523-30.
20. Ono M. Ventricular assist device and heart transplantation in Japan. Masui. 2009;58(3):327-36.
21. Jeevanandam V. Are we ready to implant left ventricular assist devices in "Less Sick" patients? Semin Thorac Cardiovasc Surg. 2012;24(1):8-10.
22. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31(2):117-26.